NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. USO
8. HOOD
9. DFTX
10. IBM

Go back to NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

NeoGenomics (NEO) Tops Q2 EPS by 1c

July 24, 2018 7:03 AM EDT

NeoGenomics (NASDAQ: NEO) reported Q2 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $67.7 million versus the consensus estimate of $66.18 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

... More